Innovation
46 patent families (18 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 4,750 times.
| Year | Filings |
|---|---|
| 2021 | 7 |
| 2022 | 29 |
| 2023 | 34 |
| 2024 | 28 |
| 2025 | 26 |
| 2026 | 10 |
Social engagement
Social engagement: 9.1K social following, 4 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Canaan, Samsara BioCapital, The Column Group, Janus Henderson Investors.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 67% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 3 | 25% |
Recent activity
12 Nov 2025
Event
SITC Annual Meeting segment on BiotechTV
30 Oct 2025
Event
SITC annual meeting
